Cited by 302Genetic factors in colorectal cancerEpigenetics and DNA MethylationColorectal Cancer Treatments and Studies

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Frequent Inactivation of PTEN by Promoter Hypermethylation in Microsatellite Instability-High Sporadic Colorectal Cancers

Goel, Ajay, Arnold, Christian N., Niedzwiecki, Donna, Carethers, John M., Dowell, Jeannette M., Wasserman, Linda, Compton, Carolyn, Mayer, Robert J., Bertagnolli, Monica M., Boland, C. Richard·2004·Cancer Research

DOI 10.1158/0008-5472.can-2401-2

Open this paper in CoChat — free account

Abstract

Loss of PTEN tumor suppressor function is observed in tumors of breast, prostate, thyroid, and endometrial origin. Allelic losses in the proximity of the PTEN locus (10q23) also occur in sporadic colorectal cancers (CRCs), but biallelic inactivation of this site has not been frequently demonstrated. We hypothesized that alternative mechanisms of PTEN allelic inactivation, such as promoter hypermethylation, might be operative in CRC and that PTEN inactivation may be related to recognized forms of genomic instability. We characterized a cohort of 273 sporadic CRCs by determining their microsatellite instability (MSI) status. Of these, 146 cancers were examined for PTEN promoter methylation by methylation-specific PCR. Mutations at the poly(A)6 repeat sequences in PTEN exons 7 and 8 and deletions at the 10q23 locus were also identified using microsatellite analysis. The presence of PTEN protein was determined by immunostaining, and the results were correlated with the promoter methylation status. We observed that PTEN promoter hypermethylation was a frequent occurrence in MSI-high (MSI-H) tumors (19.1% of MSI-H versus 2.2% of MSI-low/microsatellite stable tumors; P = 0.002). A PTEN mutation or a deletion event was present in 60% of the tumors with promoter region hypermethylation. Hypermethylation of the PTEN promoter correlated significantly with either decreased or complete loss of PTEN protein expression (P = 0.004). This is the first demonstration of PTEN inactivation as a result of promoter hypermethylation in MSI-H sporadic CRCs. These data suggest that this silencing mechanism plays a major role in PTEN inactivation and, in colon cancer, may be more important than either allelic losses or inactivating mutations. The significant correlation of PTEN hypermethylation with MSI-H tumors further suggests that PTEN is an additional important “target” of methylation along with the hMLH1 gene in the evolution of MSI-H CRCs and also confers the “second hit” in the biallelic inactivation mechanism for some proportion of tumors.

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-2401-2

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.
Herman, J. G., Graff, J. R., Myöhänen, S., Nelkin, B. D., & Baylin, S. B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9821 · Cited by 5,634
PTEN , a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer
Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., et al. (1997) · Science · doi:10.1126/science.275.5308.1943 · Cited by 4,785
A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.
Boland, C. R., Thibodeau, S. N., Hamilton, S. R., Sidransky, D., Eshleman, J. R., Burt, R. W., Meltzer, S. J., Rodrı́guez-Bigas, M. A., Fodde, R., Ranzani, G. N., et al. (1998) · PubMed · Cited by 4,087
Self-citation
Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers
Steck, P. A., Pershouse, M. A., Jasser, S. A., Yung, W. K. A., Lin, H., Ligon, A. H., Langford, L. A., Baumgard, M. L., Hattier, T., Davis, T., et al. (1997) · Nature Genetics · doi:10.1038/ng0497-356 · Cited by 2,742
The Multiple Roles of PTEN in Tumor Suppression
Di Cristofano, A., & Pandolfi, P. P. (2000) · Cell · doi:10.1016/s0092-8674(00)80674-1 · Cited by 1,182
Crystal Structure of the PTEN Tumor Suppressor
Lee, J., Yang, H., Georgescu, M.-M., Cristofano, A. D., Maehama, T., Shi, Y., Dixon, J. E., Pandolfi, P. P., & Pavletich, N. P. (1999) · Cell · doi:10.1016/s0092-8674(00)81663-3 · Cited by 1,032
Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability.
Cunningham, J. M., Christensen, E. R., Tester, D. J., Kim, C. Y., Roche, P. C., Burgart, L. J., & Thibodeau, S. N. (1998) · PubMed · Cited by 863
Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression
Whang, Y. E., Wu, X., Suzuki, H., Reiter, R. E., Tran, C., Vessella, R. L., SAID, J. W., Isaacs, W. B., & Sawyers, C. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.9.5246 · Cited by 639
PTEN: a tumour suppressor that functions as a phospholipid phosphatase
Maehama, T. (1999) · Trends in Cell Biology · doi:10.1016/s0962-8924(99)01519-6 · Cited by 599
PTEN/MMAC1 mutations in endometrial cancers.
Risinger, J. I., Hayes, A. K., Berchuck, A., & Barrett, J. C. (1997) · PubMed · Cited by 509

Show all 35 references

Sorted by citations

Items 201–300 of 302

PUM1 Is Overexpressed in Colon Cancer Cells With Acquired Resistance to Cetuximab
Liu, Q., Xin, C., Chen, Y., Yang, J., Chen, Y., Zhang, W., & Ye, L. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.696558 · Cited by 13
Diagnostic significance of DNA methylation of PTEN and DAPK in thyroid tumors
Feng, W., Wu, Y., Wang, Z., Li, Y., Wang, J., Shao, G., Yang, Y., & Shi, B. (2020) · Clinical Endocrinology · doi:10.1111/cen.14192 · Cited by 13
Association betweenPTENIVS4 polymorphism and development of colorectal cancer in a Turkish population
Canbay, E., Kahraman, Ö. T., Buğra, D., Çaykara, B., Seyhan, M. F., Bulut, T., Yamaner, S., & Öztürk, O. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2013.727398 · Cited by 12
PTEN mutation, loss of heterozygosity, promoter methylation and expression in colorectal carcinoma: Two hits on the gene?
Hühns, M., Salem, T., Schneider, B., Krohn, M., Linnebacher, M., & Prall, F. (2014) · Oncology Reports · doi:10.3892/or.2014.3097 · Cited by 12
Construction of the novel immune risk scoring system related to CD8+ T cells in uterine corpus endometrial carcinoma
Zhang, G., Yin, Z., Fang, J., Wu, A., Chen, G., & Cao, K. (2023) · Cancer Cell International · doi:10.1186/s12935-023-02966-y · Cited by 11
PTENhypermethylation profiles of Chinese Kazakh patients with esophageal squamous cell carcinoma
Pan, Q. F., Li, W. T., Dong, H. C., Chen, Y. Z., Yin, L., Liu, W., Wang, W. W., Liu, D., Li, S. G., Gu, W., et al. (2013) · Diseases of the Esophagus · doi:10.1111/dote.12106 · Cited by 11
Source, co-occurrence, and prognostic value of PTEN mutations or loss in colorectal cancer
Serebriiskii, I. G., Pavlov, V. A., Andrianov, G. V., Litwin, S., Basickes, S., Newberg, J. Y., Frampton, G. M., Meyer, J. E., & Golemis, E. A. (2023) · npj Genomic Medicine · doi:10.1038/s41525-023-00384-7 · Cited by 11
PI3Ks—Drug Targets in Inflammation and Cancer
Wymann, M. P. (2012) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-007-3012-0_5 · Cited by 11
Traditional Serrated Pathway–associated Colorectal Carcinoma
Tsai, J., Jeng, Y., Yuan, C., Lin, Y., Cheng, M.-L., & Liau, J. (2019) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000001274 · Cited by 11
Can we accurately report PTEN status in advanced colorectal cancer?
Hocking, C. M., Hardingham, J. E., Broadbridge, V. T., Wrin, J., Townsend, A. R., Tebbutt, N. C., Cooper, J. E., Ruszkiewicz, A. R., Lee, C. K., & Price, T. J. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-128 · Cited by 12
Reciprocal negative feedback regulation of ATF6α and PTEN promotes prostate cancer progression
Feng, T., Zhao, R., Zhang, H., Sun, F., Hu, J., Wang, M., Qi, M., Liu, L., Gao, L., Xiao, Y., et al. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04940-3 · Cited by 10
Mutation of HELLS, a Chromatin Remodeling Gene, Gastric and Colorectal Cancers
Choi, Y. J., Yoo, N. J., & Lee, S. H. (2014) · Pathology & Oncology Research · doi:10.1007/s12253-014-9862-y · Cited by 10
Challenges of Neoantigen Targeting in Lynch Syndrome and Constitutional Mismatch Repair Deficiency Syndrome
Abidi, A., Gorris, M. A. J., Brennan, E., Jongmans, M. C. J., Weijers, D., Kuiper, R. P., de Voer, R. M., Hoogerbrugge, N., Schreibelt, G., & de Vries, I. J. M. (2021) · Cancers · doi:10.3390/cancers13102345 · Cited by 11
PTEN Promoter Methylation And Expression In Endometrial Cancer Tissues
Khatami, F., Shahriari, S., Aminimoghaddam, S., Klashami, Z. N., Farahani, M. S., Teimoori‐Toolabi, L., Amoli, M. M., Asadi, M., & Rashidi, B. H. (2023) · Epigenomics · doi:10.2217/epi-2023-0099 · Cited by 9
Functional genomics and transcriptomics of prostate cancer: promises and limitations
Kallioniemi, O. (2005) · British Journal of Urology · doi:10.1111/j.1464-410x.2005.05941.x · Cited by 9
Association of genetic polymorphisms in PTEN and additional interaction with alcohol consumption and smoking on colorectal cancer in Chinese population.
Han, M., Wu, G., Sun, P., Nie, J., Zhang, J., & Li, Y. (2015) · PubMed Central · Cited by 8
Impact of LINE-1 hypomethylation on the clinicopathological and molecular features of colorectal cancer patients
Kuan, T., Lin, P.-C., Yang, S., Lin, C., Lan, Y., Lin, H., Liang, W.-Y., Chen, W.-S., Lin, J.-K., Jiang, J., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0197681 · Cited by 8
Review: Beyond KRAS: perspectives on new potential markers of intrinsic and acquired resistance to epidermal growth factor receptor inhibitors in metastatic colorectal cancer
Loupakis, F., Cremolini, C., Fontanini, G., Stasi, I., Salvatore, L., & Falcone, A. (2009) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758834009348984 · Cited by 8
Reduced expression of TGF β1RII in agnogenic myeloid metaplasia is not due to mutation or methylation
Hemavathy, K. C., Chang, T. H., Zhang, H., Charles, W., Goldberg, A., Aithal, S., Novetsky, A. D., & Wang, J. C. C. (2005) · Leukemia Research · doi:10.1016/j.leukres.2005.06.010 · Cited by 8
The Roles of PTEN in Melanoma Suppression
Parkman, G. L., Xu, X., Holmen, S. L., & Karreth, F. A. (2025) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.70054 · Cited by 7
Prognostic and Predictive Value of RAS Gene Mutations in Colorectal Cancer: Moving Beyond KRAS Exon 2
Boeckx, N., Peeters, M., Camp, G. V., Pauwels, P., de Beeck, K. O., & Deschoolmeester, V. (2015) · Drugs · doi:10.1007/s40265-015-0459-x · Cited by 7
Panitumumab for the Treatment of Metastatic Colorectal Cancer: A Review
Prete, M. D., Giampieri, R., Faloppi, L., Bianconi, M., Bittoni, A., Andrikou, K., & Cascinu, S. (2015) · Immunotherapy · doi:10.2217/imt.15.46 · Cited by 7
CRISPR-Cas9 based knockout of S100A8 in mammary epithelial cells enhances cell proliferation and triggers oncogenic transformation via the PI3K-Akt pathway: Insights from a deep proteomic analysis
Singh, P., Ali, S. A., Kumar, S., & Mohanty, A. K. (2023) · Journal of Proteomics · doi:10.1016/j.jprot.2023.104981 · Cited by 6
Analysis of genomic instability in adult-onset celiac disease patients by microsatellite instability and loss of heterozygosis
Fundia, A. F., Cottliar, A., Motta, G. L., Crivelli, A., Gómez, J. C., Slavutsky, I. R., & Larripa, I. B. (2008) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e3283094ee9 · Cited by 6
Analysis of PTEN expression in large intestine polyps and its relation to the recognized histopathological and clinical risk factors for cancer development in this location
Waniczek, D., Śnietura, M., Pigłowski, W., Rdes, J., Kopeć, A., Młynarczyk-Liszka, J., Rudzki, M., Hudyka, K., Arendt, J., & Lange, D. (2012) · Współczesna Onkologia · doi:10.5114/wo.2012.30059 · Cited by 6
High-Throughput Screening Strategies for Targeted Identification of Therapeutic Compounds in Colorectal Cancer
Bialkowska, A. B., & Yang, V. W. (2012) · Future Oncology · doi:10.2217/fon.12.19 · Cited by 7
Genes and Common Diseases : Genetics in Modern Medicine
Wright, A. P. H., & Hastie, N. D. (2007) · Cited by 6
NRAS mutant E132K identified in young-onset sporadic colorectal cancer and the canonical mutants G12D and Q61K affect distinct oncogenic phenotypes
Yu, R. T. D., & Garcia, R. L. (2020) · Scientific Reports · doi:10.1038/s41598-020-67796-8 · Cited by 6
Role of Tumor Suppressor PTEN and Its Regulation in Malignant Transformation of Endometrium
Perevalova, A. M., Kobelev, V. S., Сисакян, В. Г., Gulyaeva, L. F., & Pustylnyak, V. O. (2022) · Biochemistry (Moscow) · doi:10.1134/s0006297922110104 · Cited by 6
Identification and Somatic Characterization of the Germline PTEN Promoter Variant rs34149102 in a Family with Gastrointestinal and Breast Tumors
Disciglio, V., Sanese, P., Fasano, C., Lotesoriere, C., Valentini, A. M., Forte, G., Signorile, M. L., Marco, K. D., Grossi, V., Lolli, I. R., et al. (2022) · Genes · doi:10.3390/genes13040644 · Cited by 6
Plasma miR-183-5p in colorectal cancer patients as potential predictive lymph node metastasis marker
Sanjabi, F., Nekouian, R., Akbari, A., Mirzaei, R., & Fattahi, A. (2021) · Journal of Cancer Research and Therapeutics · doi:10.4103/jcrt.jcrt_174_20 · Cited by 5
A Novel CRISPR/Cas9-mediated Mouse Model of Colon Carcinogenesis
Kashima, H., Fischer, A. D., Veronese-Paniagua, D., Gazit, V. A., Ma, C., Yan, Y., Levin, M. S., Madison, B., & Rubin, D. C. (2024) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2024.101390 · Cited by 5
Epigenetics could explain some Moroccan population colorectal cancers peculiarities: microsatellite instability pathway exploration
Sekal, M., Ameurtesse, H., Chbani, L., Ouldim, K., Bennis, S., Abkari, M. E., Boulouz, A., Benajah, D., Benjelloun, B., Ousadden, A., et al. (2015) · Diagnostic Pathology · doi:10.1186/s13000-015-0326-9 · Cited by 5
Papel de la vía fosfatidilinositol 3 kinasa(PI3K/Akt) en humanos
Pinzón, C. E., Serrano, M. L., & Sanabria, M. C. (2009) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 5
The role of PI-3 kinase in cancer biology and approaches to the therapeutics of cancer
Vimalanathan, A. B., Raja, A., & Tyagi, M. G. (2009) · Biology and medicine · Cited by 5
Tracking profiles of genomic instability in spontaneous transformation and tumorigenesis
Lawrenson, L. (2010) · Human Biology · Cited by 5
Cause and effect in epigenetics – where lies the truth, and how can experiments reveal it?
Klutstein, M. (2020) · BioEssays · doi:10.1002/bies.202000262 · Cited by 4
The role of exo‐miRNA in diagnosis and treatment of cancers, focusing on effective miRNAs in colorectal cancer
Al-Shukri, H. H. K., Ali, S., Al‐Akkam, K. A., Hjazi, A. M., Rasulova, I., Mustafa, Y. F., Al‐Saidi, D. N., Alasheqi, M. Q., Alawadi, A. H., & Alsaalamy, A. H. (2024) · Cell Biology International · doi:10.1002/cbin.12122 · Cited by 4
Interweaving Tumor Heterogeneity into the Cancer Epigenetic/Metabolic Axis
Leung, J. Y., Chia, K., Ong, D. S. T., & Taneja, R. (2019) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.7942 · Cited by 4
Coexpression of biological key modulators in primary colorectal carcinomas and related metastatic sites: implications for treatment with cetuximab
Barbier, A., Dômont, J., Magné, N., Goldmard, J.-L., Genestie, C., Hannoun, C., Vaillant, J., Bellanger, A., Khayat, D., Capron, F., et al. (2010) · Bulletin du Cancer · doi:10.1684/bdc.2010.1033 · Cited by 4
The Cancer and Leukemia Group B Pathology Committee at 50
Compton, C. C. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-9009 · Cited by 4
Self-citation
FISH analysis of PTEN in endometrial carcinoma. comparison with SNP arrays and MLPA
Maiques, Ó., Cuevas, D., Garcia-Dios, D. A., Coenegrachts, L., Santacana, M., Velasco, A., Romero, M., Gatius, S., Lambrechts, D., Müller, S., et al. (2014) · Histopathology · doi:10.1111/his.12396 · Cited by 3
EGFR and FGFR in Growth and Metastasis of Colorectal Cancer
Dariya, B., Merchant, N., Aliya, S., Alam, A., & Nagaraju, G. P. (2018) · Springer eBooks · doi:10.1007/978-981-13-1486-5_11 · Cited by 3
Association of colorectal cancer with genetic and epigenetic variation in PEAR1—A population-based cohort study
Yang, W., Izzi, B., Bress, A. P., Thijs, L., Citterio, L., Wei, F., Salvi, E., Carpini, S. D., Manunta, P., Cusi, D., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0266481 · Cited by 3
Predictive Biomarkers for Monoclonal Antibody Therapies Targeting EGFR (Cetuximab, Panitumumab) in the Treatment of Metastatic Colorectal Cancer
Sakthianandeswaren, A., Sabljak, P., Elliott, M. J., Palmieri, M., & Sieber, O. M. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.80690 · Cited by 3
Epigenetic modification of chromatin
Dunican, D. S., Pennings, S., & Meehan, R. R. (2007) · Cambridge University Press eBooks · doi:10.1017/cbo9780511543555.003 · Cited by 2
The Cross-Talk between Epigenetic Gene Regulation and Signaling Pathways Regulates Cancer Pathogenesis
Samanta, S., Mahata, R., & Santra, M. K. (2022) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-031-07634-3_13 · Cited by 2
Molecular mechanism of colorectal cancer and screening of molecular markers based on bioinformatics analysis
Zhao, J., Kuang, D., Cheng, X., Geng, J., Huang, Y., Zhao, H., & Yang, Z. (2023) · Open Life Sciences · doi:10.1515/biol-2022-0687 · Cited by 2
Role of epigenetics, DNA methylation, histone modification, and microRNA in different cancers
Jain, K. M., & Rana, R. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95258-3.00003-5 · Cited by 2
PIK3CB Inhibitor GSK2636771 in Cancers With PTEN Mutation/Deletion or Loss of PTEN Protein Expression: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols N and P
Jankú, F., Jegede, O. A., Puhalla, S. L., Konstantinopoulos, P. A., Meric‐Bernstam, F., Zwiebel, J. A., Gray, R. J., Wang, V., McShane, L. M., Rubinstein, L., et al. (2025) · JCO Precision Oncology · doi:10.1200/po-25-00265 · Cited by 2
Biomarkers in Gastrointestinal Cancer: Focus on Colon, Pancreatic and Gastric Cancer
Deschoolmeester, V., Lardon, F., Pauwels, P., & Peeters, M. (2012) · InTech eBooks · doi:10.5772/38481 · Cited by 2
Anti-EGFR Resistance in Colorectal Cancer: Current Knowledge and Future Perspectives
Boeckx, N., de Beeck, K. O., Deschoolmeester, V., Camp, G. V., Pauwels, P., & Peeters, M. (2014) · Current Colorectal Cancer Reports · doi:10.1007/s11888-014-0242-5 · Cited by 2
BRAF, KRAS, and Phosphatidylinositol 3-Kinase in the Management of Metastatic Colorectal Cancer
Coutinho, A. K., Prolla, G., & Weschenfelder, R. F. (2013) · Current Colorectal Cancer Reports · doi:10.1007/s11888-012-0152-3 · Cited by 2
Papel de la vía fosfatidilinositol 3 kinasa(PI3K/Akt) en humanos
Pinzón, C. E., Serrano, M. L., & Sanabria, M. C. (2009) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 7
Resistance of Colorectal Tumors to Anti-EGFR Antibodies
Trusolino, L., & Leto, S. M. (2018) · Resistance to targeted anti-cancer therapeutics · doi:10.1007/978-3-319-67932-7_1 · Cited by 2
Uterine cervical neoplasia : aspects of biology and pathology
Bertelsen, B. I. (2007) · NORA - Norwegian Open Research Archives · Cited by 2
PTEN Regulates Myofibroblast Activation in Valvular Interstitial Cells Based on Subcellular Localization
Batan, D., Tseropoulos, G., Kirkpatrick, B. E., Bishop, C., Bera, K., Khang, A., Weiser-Evans, M. C. M., & Anseth, K. S. (2025) · Advanced Biology · doi:10.1002/adbi.202400540 · Cited by 1
Trithorax Genes in Prostate Cancer
Clermont, P., Crea, F., & Cheryl, D. (2013) · InTech eBooks · doi:10.5772/52905 · Cited by 1
Clement Richard Boland, Jr., MD: A Conversation with the Editor
Boland, C. R. (2004) · Baylor University Medical Center Proceedings · doi:10.1080/08998280.2004.11928011 · Cited by 1
Self-citation
Chemo- and Radiosensitization Through Inhibition of PI3K/Akt Signaling
Smith, D. L., Nolden, L. K., Mills, G. B., & Lu, Y. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-221-2_17 · Cited by 1
Biomarkers in Advanced Colorectal Cancer: Challenges in Translating Clinical Research into Practice
Lemech, C., & Arkenau, H. (2011) · Cancers · doi:10.3390/cancers3021844 · Cited by 2
DNA methylation of PTEN gene promoter region is not correlated with urocystic tumorigenesis
Sun, X. (2012) · AFRICAN JOURNAL OF BIOTECHNOLOGY · doi:10.5897/ajb11.2955 · Cited by 1
PTEN at 18: Still Growing
Gorbenko, O., & Stambolic, V. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-3299-3_2 · Cited by 1
Genetic and epi-genetic alterations of the PTEN gene: key in the relationship between type 2 diabetes and cancer
Schimpf, A. R. A., Formichela, M. M., Mascheroni, M. B., Rivero, D., Chamorro, M. L., Portillo, V., Zapata, P. D., & Ferri, C. A. (2022) · Revista de Ciencia y Tecnología · doi:10.36995/j.recyt.2022.37.009 · Cited by 1
The additive interaction of healthy lifestyles and genetic susceptibility on colorectal cancer risk in prediabetes: a large population-based prospective cohort study
Wang, W., Cheng, Y.-K., Meng, Q., Jia, B., Yao, D., & Cheng, Y.-P. (2024) · BMC Gastroenterology · doi:10.1186/s12876-024-03552-w
Aberrant Methylation Profile and Microsatellit Instability in Turkish Sporadic Colorectal Carcinoma
Ekmekçi, C. G., GULLUOGLU, M. G., Kapran, Y., Dizdaroğlu, F., & Özbek, U. (2019) · Bezmialem Science · doi:10.14235/bas.galenos.2018.2456 · Cited by 1
Signaling pathways in CRC
Santos, V. S., Lago, N. M., García, C. P., García, A. P., & Aparicio, L. M. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-90055-3.00043-0 · Cited by 1
A Review on Cancer, Cause of Cancer and Treatment: Role of PIK3 Pathway on Cancer
Choudhary, M. L., & Sisodia, S. S. (2023) · Bioequivalence & Bioavailability International Journal · doi:10.23880/beba-16000208
Functional analysis of Rim3 mutation that exhibits aberrant epidermal morphogenesis.
田中, 成., タナカ, シ., & Tanaka, S. (2004) · SOKENDAI (Graduate University for Advanced Studies) · Cited by 1
Mechanisms of Resistance to Epidermal Growth Factor Receptor (EGFR) in Non‐Small Cell Lung Cancer
Massarelli, E. (2014) · Lung Cancer · doi:10.1002/9781118468791.ch27 · Cited by 1
PI3K/PTEN signaling in liver diseases
Fort, A., Calo, N., Portius, D., Bourgoin, L., Peyrou, M., & Foti, M. (2015) · Wiley eBooks · doi:10.1002/9781118663387.ch21 · Cited by 1
Cancer and Leukemia Group B Gastrointestinal Cancer Committee
Goldberg, R. M., Niedzwiecki, D., Bertagnolli, M. M., Blackstock, A. W., Tepper, J. E., & Mayer, R. J. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-9004 · Cited by 1
Self-citation
Translational control : mTOR signalling and the use of next-generation sequencing methods
Jackson, T. J. (2013) · Nottingham ePrints (University of Nottingham)
The effects of Phosphatase and Tensin Homolog (PTEN) overexpression on longevity of cultured Human Umbilical Vein Endothelial Cells (HUVEC)
Tait, I. (2014) · Tuwhera (Auckland University of Technology)
Intracellular Signal Transduction Cascades
Matthews, D. J., & Gerritsen, M. E. (2010) · Wiley eBooks · doi:10.1002/9780470555293.ch5
The effects of aberrant Wnt signalling on the murine intestinal stem cell compartment
Young, M. A. (2013) · ORCA Online Research @Cardiff (Cardiff University)
Localization and functional study of VEGF receptors in normal and adenomatous pituitary: evidence for a non-angiogenic role of VEGF
Onofri, C. (2006) · Elektronische Hochschulschriften der LMU München (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.5362
Relationship between promoter methylation and mRNA expression of PTEN gene and gastric carcinoma
Liu, S., Yu, J., Fu, P., & Yu, H. (2008) · The Chinese-German Journal of Clinical Oncology · doi:10.1007/s10330-008-0081-4
Re: Decreased STAT1 Expression by Promoter Methylation in Squamous Cell Carcinogenesis
Wong, T., Liu, X.-B., Ng, R. W.-M., Wei, W., & Yuen, A. P. W. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm091
PI3K
Courtney, K. D., & Cantley, L. C. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139046947.019
Selected genes involved in GIST evolution from indolent to advanced tumours
Quattrone, A. (2015)
REVIEWS IN BASIC AND CLINICAL GASTROENTEROLOGY AND HEPATOLOGY Epigenetics of Colorectal Cancer
Goel, A., & Boland, C. R. (2012)
Self-citation
Genai svarbūs storosios žarnos vėžio patogenezėje
Raulinaitytė, D., Ugenskienė, R., Jančiauskienė, R., Juozaitytė, E., & Kairevičė, L. (2012) · Sveikatos mokslai · doi:10.5200/sm-hs.2012.101
Epigenetic Control of Genes Involved in Cancer Initiation and Progression
Saldanha, S. N., & Soni, S. (2016) · Springer eBooks · doi:10.1007/978-3-319-24951-3_1
Predictive Markers in Colon Cancer
Gerger, A., LaBonte, M. J., & Lenz, H. (2012) · Springer eBooks · doi:10.1007/978-1-4419-9755-5_1
Towards functional multiscale analysis of colorectal cancer
Briffa, R. (2014) · ERA
Resistance to Tyrosine Kinase Inhibitors in Different Types of Solid Cancer
Mirone, G., Perna, S., & Marfè, G. (2016) · Resistance to targeted anti-cancer therapeutics · doi:10.1007/978-3-319-46091-8_2
Farmacogenética en el tratamiento del cáncer colorrectal
López-Bravo, D. P. (2012) · TDX (Tesis Doctorals en Xarxa)
Neoplasia of the Gastrointestinal Tract
Margalit, O., & DuBois, R. N. (2015) · Wiley eBooks · doi:10.1002/9781118512074.ch31
Immunomodulation and Vaccination with RHDV VLP
Donaldson, B. (2017) · Otago University Research Archive (University of Otago)
Molecular determinants of therapeutic response to targeted therapies in metastatic colorectal cancer
Weickhardt, A. J. (2011) · Minerva Access (University of Melbourne)
Drug Resistance Against Tyrosine Kinase Inhibitor in Gastrointestinal Malignancies
Bhaskar, L. V., & Saikrishna, L. (2018) · Springer eBooks · doi:10.1007/978-981-13-1486-5_14
Alterations in PTEN and PIK3CA in colorectal cancers in the EPIC Norfolk study
Naguib, A., Cooke, J. C., Happerfield, L. C., Kerr, L., Luben, R., Ball, R. Y., Mitrou, P. N., McTaggart, A., & Arends, M. J. (2016)
Tumor Environment Modulation and Modeling through Exosomal Delivery of microRNAs in Colorectal Cancer Organoids
Bakerman, I. (2020) · UA Campus Repository (The University of Arizona)
Supplementary References from Genome-Wide Analysis of Promoter Methylation Associated with Gene Expression Profile in Pancreatic Adenocarcinoma
Vincent, A., Omura, N., Hong, S., Jaffe, A., Eshleman, J. R., & Goggins, M. (2023) · doi:10.1158/1078-0432.22441000
Supplementary References from Genome-Wide Analysis of Promoter Methylation Associated with Gene Expression Profile in Pancreatic Adenocarcinoma
Vincent, A., Omura, N., Hong, S., Jaffe, A., Eshleman, J. R., & Goggins, M. (2023) · doi:10.1158/1078-0432.22441000.v1
Induction of apoptosis in the presence of natural polyphenols and expression profile of K-Ras and Akt1 in breast cancer cell line MDA-MB-231
Singh, A. (2014)
Rôle de la protéine sécrétée OLFM4 dans la carcinogénèse colorectale et mammaire : importance du contexte cellulaire
Rideau, A. (2017) · theses.fr (ABES) · doi:10.70675/1e724eebz5eeaz48f0za621z4d96e4fb08e2
Régulation de l’expression d’UNC5A par l’axe OGT/EZH2 : une nouvelle connexion entre nutrition, épigénétique et cancer colorectal ?
Decourcelle, A. (2020) · theses.fr (ABES) · doi:10.70675/87e0f193zd68ez4f36za232zeb8da49e1062
Targeting molecular and genetic pathways driving tumorigenesis for precision therapy in colorectal cancer
Doermann, A. S., Caspi, A., Evans, A. E., Feci, A., Entezari, A. A., Snook, A. E., & Waldman, S. A. (2026) · Cancer Biology & Therapy · doi:10.1080/15384047.2026.2683096

Authors: Goel, A., Arnold, C. N., Niedzwiecki, D., Carethers, J. M., Dowell, J. M., Wasserman, L., Compton, C., Mayer, R. J., Bertagnolli, M. M., & Boland, C. R.
Affiliations: University of California San Diego (US)
Duke University (US)
McGill University (CA)
Dana-Farber Cancer Institute (US)
Brigham and Women's Hospital (US)
United States Department of Veterans Affairs (US)
ORCID: Goel, Ajay
Arnold, Christian N.
Niedzwiecki, Donna
Carethers, John M.
Compton, Carolyn
Mayer, Robert J.
Bertagnolli, Monica M.
Boland, C. Richard
Venue: Cancer Research
Publisher: American Association for Cancer Research (AACR)
Published: 2004-05-01
Volume: 64
Issue: 9
Pages: 3014-3021
ISSN: 0008-5472 (ISSN-L)
1538-7445
DOI: 10.1158/0008-5472.can-2401-2
OpenAlex: W2054894450
Cited by: 302
References: 35
Citations by year: 2026: 2 · 2025: 3 · 2024: 8 · 2023: 12 · 2022: 9 · 2021: 11 · 2020: 12 · 2019: 12 · 2018: 13 · 2017: 5 · 2016: 12 · 2015: 19 · 2014: 17 · 2013: 27 · 2012: 30
FWCI: 10.72
Type: journal article
Language: en
Open access: closed
Locations: Cancer Research (publishedVersion)
PubMed (publishedVersion)
FreiDok plus (Universitätsbibliothek Freiburg) (submittedVersion)
Funders: University of California, San Diego
National Cancer Institute (R01-CA-72851, R01CA072851, R01 CA90231, R01CA090231, U10CA031946, CA-31946)
Topics: Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
Keywords: PTEN, promoter hypermethylation, microsatellite instability, sporadic colorectal cancer, tumor suppressor inactivation, PTEN mutation, PTEN protein expression, genomic instability, second hit, DNA methylation
MeSH terms: Aged, Alleles, Chromosomes, Human, Pair 10, Female, Humans, Male, Middle Aged, Mutation, Phosphoric Monoester Hydrolases, Promoter Regions, Genetic, Colorectal Neoplasms, Gene Expression Regulation, Neoplastic, Microsatellite Repeats, DNA Methylation, Loss of Heterozygosity, Gene Silencing, Tumor Suppressor Proteins, PTEN Phosphohydrolase

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Frequent Inactivation of PTEN by Promoter Hypermethylation in Microsatellite Instability-High Sporadic Colorectal Cancers

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks